Ads
related to: pathophysiology of t2dm cancer treatment ppt- 2L mNSCLC Treatment
For Metastatic
NSCLC. Visit Physician Site.
- Dosing & Administration
View Dosing & Preparation Info For
A 2L mNSCLC Treatment Option.
- Efficacy & Safety Data
See If A 2L mNSCLC Treatment
Is An Option For Your Patients.
- mNSCLC Biomarker Info
Discover A Treatment For 2L mNSCLC
With This Actionable Biomarker
- Mechanism Of Action Info
See How A 2L Metastatic
NSCLC Therapy Works.
- Resources For Physicians
Downloadable Resources For Your
mNSCLC Patients & Their Caregivers.
- 2L mNSCLC Treatment
cancer.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
However, there is growing evidence that T2DM is not only a purely metabolic, but also an inflammatory disorder. The link between certain TLR4 SNPs alleles and T2DM may be directly related to elevated TLR4 expression since its signaling can regulate diet-induced obesity and insulin resistance and, therefore, influence the pathogenesis of T2DM.
Individuals with cancer may be at a higher risk of mortality if they also have diabetes. [53] Testosterone deficiency is also associated with type 2 diabetes. [54] [55] Eating disorders may also interact with type 2 diabetes, with bulimia nervosa increasing the risk and anorexia nervosa decreasing it. [56]
Thiazolidinedione ligand dependent transactivation is responsible for the majority of anti-diabetic effects. The activated PPAR/RXR heterodimer binds to peroxisome proliferator hormone response elements upstream of target genes in complex with a number of coactivators such as nuclear receptor coactivator 1 and CREB binding protein, this causes upregulation of genes (for a full list see PPARγ):
In the early days of insulin treatment for type 1 diabetes there was much debate as to whether strict control of hyperglycaemia would delay or prevent the long-term complications of diabetes. The work of Pirart [ 50 ] suggested that microvascular complications of diabetes were less likely to occur in individuals with better glycaemic control.
Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. While it is often mistaken for diabetes or hyperglycaemia, hyperinsulinemia can result from a variety of metabolic diseases and conditions, as well as non-nutritive sugars in the diet.
n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It raises the concentration of glucose and fatty acids in the bloodstream and is considered to be the main catabolic hormone of the body. It is also used as a medication ...